Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
-
Field
-
employment. KU Leuven and VIB provide language training facilities that will support you with this. How to apply Deadline: 15 November 2026. Please apply via the online application tool ( https://jobs.vib.be
-
Early Career Group Leader Position in Cancer Immunobiology Leuven VIB-KU Leuven Center for Cancer Biology Group Leader / PI Posted Date 16 Oct 2026 Locations Leuven Center VIB-KU Leuven Center for
-
18 Sep 2026 Job Information Organisation/Company KU LEUVEN Research Field Computer science » Informatics Engineering » Biomedical engineering Engineering » Computer engineering Biological sciences
-
23 Sep 2026 Job Information Organisation/Company KU LEUVEN Department Mechanical Engineering Research Field Engineering » Precision engineering Engineering » Mechanical engineering Researcher Profile
-
2 Oct 2026 Job Information Organisation/Company KU LEUVEN Research Field Engineering » Computer engineering Computer science » Informatics Engineering » Biomedical engineering Computer science
-
20 Aug 2026 Job Information Organisation/Company KU LEUVEN Research Field Engineering » Chemical engineering Researcher Profile Established Researcher (R3) Application Deadline 3 Nov 2026 - 23:59
-
2026-2027 International PhD Call VIB CNL Leuven VIB-KU Leuven Center for Neuroscience PhD Posted Date 18 Oct 2026 Locations Leuven Center VIB-KU Leuven Center for Neuroscience Type PhD Positions 4
-
9 Sep 2026 Job Information Organisation/Company KU LEUVEN Research Field Engineering » Mechanical engineering Researcher Profile First Stage Researcher (R1) Application Deadline 30 Sep 2026 - 23:59
-
29 Aug 2026 Job Information Organisation/Company KU LEUVEN Research Field Engineering » Civil engineering Engineering » Systems engineering Engineering » Computer engineering Engineering » Control
-
VIB Center for Cancer Biology (VIB CCB) and the Department of Oncology, KU Leuven are recruiting a group leader/professor in Cancer Biology with a research focus on the cross talk between cancer cells